VILLANI, GUGLIELMO ROSARIO DOMENICO
 Distribuzione geografica
Continente #
EU - Europa 9.151
NA - Nord America 2.700
AS - Asia 2.531
SA - Sud America 442
AF - Africa 70
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.900
Nazione #
IT - Italia 6.539
US - Stati Uniti d'America 2.628
SG - Singapore 1.315
RU - Federazione Russa 1.059
CN - Cina 501
UA - Ucraina 413
BR - Brasile 367
VN - Vietnam 314
HK - Hong Kong 229
SE - Svezia 182
DE - Germania 167
NL - Olanda 164
FR - Francia 160
FI - Finlandia 118
GB - Regno Unito 90
IE - Irlanda 76
PL - Polonia 49
CA - Canada 46
IN - India 43
BE - Belgio 39
AR - Argentina 30
CI - Costa d'Avorio 26
CH - Svizzera 22
MX - Messico 20
BD - Bangladesh 18
RO - Romania 17
ZA - Sudafrica 16
ID - Indonesia 15
TR - Turchia 15
ES - Italia 14
PK - Pakistan 12
AT - Austria 11
EC - Ecuador 11
CO - Colombia 8
JP - Giappone 8
CL - Cile 7
IQ - Iraq 7
LT - Lituania 7
PY - Paraguay 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
EG - Egitto 5
VE - Venezuela 5
KZ - Kazakistan 4
MA - Marocco 4
TW - Taiwan 4
AU - Australia 3
GR - Grecia 3
IR - Iran 3
LK - Sri Lanka 3
PE - Perù 3
UY - Uruguay 3
UZ - Uzbekistan 3
AO - Angola 2
AZ - Azerbaigian 2
BZ - Belize 2
CY - Cipro 2
DK - Danimarca 2
DZ - Algeria 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
KR - Corea 2
KW - Kuwait 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GM - Gambi 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
MR - Mauritania 1
MZ - Mozambico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 14.897
Città #
Singapore 578
Chandler 373
Milan 363
Rome 348
Naples 347
Jacksonville 268
Beijing 248
Hong Kong 227
Moscow 218
Santa Clara 181
Palermo 167
Stockholm 158
Ashburn 157
Millbury 124
Napoli 98
Princeton 90
Bologna 87
Catania 75
Florence 72
Turin 71
Ho Chi Minh City 68
Los Angeles 61
Wilmington 60
Bari 47
Nanjing 45
Dearborn 40
Buffalo 39
Amsterdam 37
Hanoi 33
São Paulo 33
Padova 32
Waanrode 31
Dallas 29
The Dalles 29
Genoa 27
Boston 26
New York 26
Redondo Beach 26
Kronberg 24
Houston 23
Salerno 23
Helsinki 20
Latina 19
Nuremberg 19
Reggio Calabria 19
Brescia 18
Nanchang 18
Verona 18
Bergamo 17
Caserta 17
Genova 17
Ottawa 17
Redwood City 17
Rio de Janeiro 17
Seattle 17
Afragola 16
Ancona 16
Ann Arbor 16
Munich 16
Pescara 16
Tianjin 15
Torino 15
Warsaw 15
Brooklyn 14
Changsha 14
Hefei 14
Senigallia 14
Shenyang 14
Trieste 14
Hebei 13
Messina 13
Parma 13
Taranto 13
Augusta 12
Capaccio 12
Des Moines 12
Norwalk 12
Toronto 12
Venice 12
Reggio Emilia 11
Boardman 10
Chennai 10
Denver 10
Johannesburg 10
Mexico City 10
Modena 10
Mumbai 10
Novara 10
Sant'angelo In Vado 10
Torre Annunziata 10
Trento 10
Chicago 9
Guangzhou 9
London 9
Orta di Atella 9
Pune 9
Segrate 9
Vicenza 9
Acerra 8
Castellammare di Stabia 8
Totale 5.792
Nome #
Newborn screening: uno strumento per la diagnosi di difetti metabolici materni non diagnosticati 3.147
Deficit di vitamina B12 materna diagnosticati mediante screening neonatale allargato 2.577
Deficit di 3-Metilcrotonil-CoA Carbossilasi: identificazione di due nuove mutazioni 1.549
"Classical organic acidurias": diagnosis and pathogenesis. 534
Diagnosi di malattie metaboliche su sospetto clinico a confronto con dati di screening metabolico allargato 313
Mutations among Italian Mucopolysaccharidosis type I patients 147
Hypermethioninemia in Campania: Results from 10 years of newborn screening 125
Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism. 121
Echistatin inhibits adhesion of murine melanoma cells to extracellular matrix components. 119
A real benefit of an extended neonatal screening 118
Detection of four novel mutations in the iduronate-2-sulfatase gene 112
Mucopolysaccharidosis type II: identification of six novel mutations in Italian patients 111
Insulin-resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria? 111
Gene symbol: SGSH. Disease: Sanfilippo type A syndrome, mucopolysaccharidosis IIIA. 109
Effect of rat liver cytosolic enzymes and cofactors on mutagenicity of 1-amino,8-nitropyrene 107
Extraneurologic symptoms as presenting signs of Sanfilippo Disease 105
Plasma acylcarnitines and urine organic acids profiles provide evidence for possible mitochondrial dysfunction in glycogen storage disease type Ia 104
Biochemical and molecular characterization of 3-Methylcrotonylglycinuria in an Italian asymptomatic girl 104
Identification of molecular defects in Italian Sanfilippo A patients including 13 novel mutations 101
A new case of M/SCHAD deficiency: The contribution of metabolic findings in directing the definitive genetic diagnosis for an optimal management 96
Molecular genetic characterization and prenatal diagnosis in a family with Hunter disease. 95
The effect of four mutations on the expression of iduronate-2-sulfatase in mucopolysaccharidosis type II 95
Molecular markers for the follow-up of enzyme replacement therapy in mucopolysaccharidosis VI disease. 94
Heparan N-sulfatase gene: two novel mutations and transient expression of fifteen defects. 93
Effect of avarol and avarone on in vitro-induced microsomal lipid peroxidation 93
Gene symbol: IDS. Disease: mucopolysaccharidosis type II (Hunter syndrome) 93
Enhancement of tissue lipoperoxidation in propanil-treated rats 92
Influence of conjugation reactions on mammalian metabolism and DNA covalent binding of dinitropyrenes 92
Effetti delle disintegrine, proteine estratte dal veleno di vipere, sui meccanismi di adesione cellulare 92
Maroteaux-Lamy syndrome: five novel mutations and their structural localization 91
Effect of rat liver cytosolic enzymes and cofactors on mutagenicity of 1-amino,8-nitropyrene. 91
Correction of mucopolysaccharidosis type IIIB fibroblasts by lentiviral vector-mediated gene transfer 90
Analisi del covalent binding dei dinitropireni al DNA in cellule di epatoma umano in coltura HepG2 90
Prenatal diagnosis of Sanfilippo type A syndrome in a family with S66W mutant allele 88
Detection of four novel mutations in the iduronate-2-sulphatase gene 87
Treatment of the mouse model of mucopolysaccharidosis type IIIB with lentiviral-NAGLU vector 87
Long-term monitoring for short/branched-chain acyl-CoA dehydrogenase deficiency: A single-center 4-year experience and open issues 86
Expression of five iduronate-2-sulfatase site-directed mutations 85
In vitro gene therapy of mucopolysaccharidosis type I by lentiviral vectors 83
Maternal VitaminB12 deficiency detected in expanded newborn screening 82
Mutazioni a differente esito nella metilmalonico acidemia di tipo mut0 ripropongono il problema del timing nello screening metabolico allargato 82
Large deletion involving exon 5 of the ARSB gene caused apparent homozygosity in a mucopolysaccharidosis type VI patient 81
Gene therapy for mucopolysaccharidosis type I and type IIIB by lentiviral vectors 78
Treatment of mucopolysaccharidosis type I by lentiviral vector transducing the human alfa-L-iduronidase gene 78
Mucopolysaccharidoses types I and IIIB: gene therapy by lentiviral vectors 78
Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector 78
Molecular defects in the alfa-N-acetylglucosaminidase gene in Italian Sanfilippo B patients 77
Molecular analysis of DNA adducts and hprt mutations produced by 6-nitrosochrysene in Chinese hamster ovary cells 77
Lentiviral vectors-mediated gene therapy for mucopolysaccharidosis type IIIB 77
Characterization of five iduronate-2-sulfatase site-directed mutations 77
Trasferimento mediato da lentivirus del cDNA umano per l'enzima NAGLU in fibroblasti di pazienti con mucopolisaccaridosi IIIB 76
An adult Sanfilippo type A patient with homozygous mutation R206P in the sulfamidase gene 76
Gene symbol: IDS. Disease: mucopolysaccharidosis type II (Hunter syndrome). 74
Lentiviral vector-mediated gene therapy for Sanfilippo B syndrome (MPS IIIB) 73
Analisi di mutazioni in pazienti Hunter 72
Molecular defects in the alfa-N-acetylglucosaminidase gene 72
Mucopolisaccaridosi tipo II (sindrome di Hunter): identificazione dello stato di portatrice della malattia mediante analisi delle mutazioni 71
Two novel mutations of the arylsulfatase B gene in two Italian patients with the severe form of mucopolysaccharidosis VI 70
Influence of Sex on Urinary Organic Acids: A Cross‐Sectional Study in Children 70
Detection of four novel mutations in the iduronate-2-sulfatase gene. 69
Heparin sulfamidase S66W allele: the first early prenatal diagnosis of Sanfilippo type A syndrome 69
Mucopolysaccharidoses: from gene defect to protein expression 69
Expression studies of Sanfilippo A mutations 69
Analysis of Sanfilippo A gene mutations in a large pedigree. 68
Identificazione e caratterizzazione di mutazioni sul gene per l'alfa-N-acetilglucosaminidasi 68
Identification of molecular alterations in Sanfilippo B patients 67
Vettori lentivirali come strumenti per la terapia genica delle mucopolisaccaridosi I e IIIB 66
Intracranial gene delivery of LV-NAGLU vector corrects neuropathology in murine MPS IIIB. 64
Gene therapy of Sanfilippo type B syndrome using a lentiviral vector 63
Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB. 63
Unfolded Protein Response is not activated in the mucopolysaccharidoses but protein disulfide isomerase 5 is deregulated 63
Mucopolysaccharidoses: from gene defect to protein expression 62
Bone Marrow transplantation in a Hunter patient with P266H mutation 61
Uptake of recombinant iduronate-2-sulfatase into neuronal and glial cells in vitro 59
Coexistence of mutations R315X and g.99367-102002del both involving the exon 5 of ARSB gene caused a misdiagnosis for a MPS VI patient. 59
Mucopolisaccaridosi IIIA: espressione in vitro di 15 difetti molecolari 58
L'echistatina inibisce l'adesione di cellule di melanoma murino B16-BL6 ai componenti della matrice extracellulare 58
“Analisi delle mutazioni nel gene dell'iduronato-2-solfatasi in pazienti Hunter” 57
Mucopolysaccharidosis type II: identification of six novel mutations in italian patients. 56
Molecular genetic characterization and prenatal diagnosis in a family with Hunter disease. 56
Mucopolysaccharidosis IIIB: oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis. 53
“Analisi delle mutazioni nel gene dell' IDS in pazienti Hunter” 53
“Mucopolisaccaridosi: studio del difetto molecolare in pazienti italiani e approccio di terapia genica” 51
Oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis of mucopolysaccharidosis IIIB 51
Studi di metabolismo della 3,4-dicloroanilina 49
“Identificazione di due nuove mutazioni in pazienti Maroteaux-Lamy italiani” 49
Fabry disease associated with G6PD definciency 49
Hurler disease bone marrow stromal cells exhibit altered ability to support osteoclast formation 49
MPS VI disease: evaluation of molecular markers for the follow-up of enzyme replacement therapy 49
Metabolic-activation of Dinitropyrenes By Human Liver Fractions 47
Molecular pathology of the mucopolysaccaridoses 45
Molecular pathology of mucopolysaccaridosis IIIB 45
Intracranial injections of lentiviral-NAGLU vector in MPS IIIB mice: effect of treatment on cytokines, neurotrophins and oxidative stress 41
A novel splicing mutation in a MPS II (Hunter syndrome) patient. 41
In vivo gene transfer for mucopolysaccharidosis type I and type IIIB animal models 38
Totale 15.080
Categoria #
all - tutte 33.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.829


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021806 0 0 0 0 0 128 137 79 178 83 121 80
2021/20221.180 56 69 66 103 66 72 40 55 133 85 164 271
2022/20231.593 156 141 89 133 168 143 103 169 207 103 102 79
2023/20241.842 106 144 163 140 133 149 163 174 87 222 195 166
2024/20253.784 263 229 116 122 157 286 369 175 311 794 767 195
2025/20262.652 496 398 428 469 745 116 0 0 0 0 0 0
Totale 15.080